Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells
Molecules · 2024
DOI: 10.3390/molecules29030597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hyun-Ji Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea. Hauptthemen laut MEDLINE: Lung Neoplasms, Campanulaceae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The aim of this study was to investigate the anti-angiogenic effects of the hexane fraction of Adenophora triphylla var. japonica root extract (HAT) and its influence on the development of erlotinib resistance in human lung cancer cells. HAT significantly reduced the migration, invasion, and tube formation of human umbilical vein endothelial cells (HUVECs). The phosphorylation levels of vascular endothelial growth factor receptor 2 (VEGFR2) and its downstream molecules were decreased via HAT, indicating its anti-angiogenic potential in endothelial cells (ECs). A docking analysis demonstrated that β-sitosterol and lupeol, representative components of HAT, exhibit a high affinity for binding to VEGFR2. In addition, conditioned media from HAT-pretreated H1299 human lung cancer cells attenuated cancer-cell-induced chemotaxis of HUVECs, which was attributed to the decreased expression of angiogenic and chemotactic factors in H1299 cells. Interestingly, co-culture of erlotinib-sensitive PC9 human lung cancer cells with HUVECs induced erlotinib resistance in PC9 cells. However, co-culture with HAT-pretreated HUVECs partially restored the sensitivity of PC9 cells to erlotinib. HAT inhibited the development of erlotinib resistance by attenuating hepatocyte growth factor (HGF) production by ECs. Taken together, our results demonstrate that HAT exerts its anticancer effects by regulating the crosstalk between ECs and lung cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea.
- Department of Biochemistry, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea.
ORCID-Profile: Yung-Hyun Choi, Shin-Hyung Park
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, H. J., Jeong, J. H., Choi, Y. H., & Park, S. H. (2024). Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells. Molecules. https://doi.org/10.3390/molecules29030597
Vancouver
Park HJ, Jeong JH, Choi YH, Park SH. Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells. Molecules. 2024. doi:10.3390/molecules29030597
BibTeX
@article{Park2024,
author = {Park, Hyun-Ji and Jeong, Jae-Hoon and Choi, Yung-Hyun and Park, Shin-Hyung},
title = {Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29030597}
}
EUVIMED